ASX - By Stock
|
MSB |
Re:
Video Thread
|
|
JSBStrikesBack
|
72 |
33K |
8 |
12/04/20 |
12/04/20 |
ASX - By Stock
|
72
|
33K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Video Thread
|
|
JSBStrikesBack
|
72 |
33K |
17 |
12/04/20 |
12/04/20 |
ASX - By Stock
|
72
|
33K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
JSBStrikesBack
|
17K |
6.8M |
9 |
12/04/20 |
12/04/20 |
ASX - By Stock
|
17K
|
6.8M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
JSBStrikesBack
|
17K |
6.8M |
21 |
12/04/20 |
12/04/20 |
ASX - By Stock
|
17K
|
6.8M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Half Year Results- Conference Call
|
|
JSBStrikesBack
|
27 |
171K |
19 |
11/04/20 |
11/04/20 |
ASX - By Stock
|
27
|
171K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
JSBStrikesBack
|
17K |
6.8M |
7 |
10/04/20 |
10/04/20 |
ASX - By Stock
|
17K
|
6.8M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
JSBStrikesBack
|
17K |
6.8M |
25 |
10/04/20 |
10/04/20 |
ASX - By Stock
|
17K
|
6.8M
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
JSBStrikesBack
|
17K |
6.8M |
35 |
10/04/20 |
10/04/20 |
ASX - By Stock
|
17K
|
6.8M
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
JSBStrikesBack
|
17K |
6.8M |
8 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
17K
|
6.8M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US NIH Trials Network to Conduct COVID-19 Phase 2/3 Trial
|
|
JSBStrikesBack
|
276 |
141K |
32 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
276
|
141K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
JSBStrikesBack
|
5.5K |
2.7M |
2 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
5.5K
|
2.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients
|
|
JSBStrikesBack
|
311 |
166K |
38 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
311
|
166K
|
38
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
JSBStrikesBack
|
23K |
13M |
10 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
23K
|
13M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients
|
|
JSBStrikesBack
|
311 |
166K |
31 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
311
|
166K
|
31
|
|
ASX - By Stock
|
SKN |
Re:
Holista (HCT) CEO - Dr Rajen Manicka discussing effectiveness of Path-Away against Corona Viruses
|
|
JSBStrikesBack
|
19 |
6.4K |
6 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
19
|
6.4K
|
6
|
|
ASX - By Stock
|
SKN |
Re:
Ann: SKN enters collaboration with HCT on natural sanitiser
|
|
JSBStrikesBack
|
154 |
48K |
4 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
154
|
48K
|
4
|
|
ASX - By Stock
|
SKN |
Re:
Ann: SKN enters collaboration with HCT on natural sanitiser
|
|
JSBStrikesBack
|
154 |
48K |
4 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
154
|
48K
|
4
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Pause in trading
|
|
JSBStrikesBack
|
1 |
915 |
0 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
1
|
915
|
0
|
|
ASX - By Stock
|
SKN |
Re:
SKN NEW PRODUCT LAUNCH INVISI SHIELD COVID-19
|
|
JSBStrikesBack
|
379 |
92K |
1 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
379
|
92K
|
1
|
|
ASX - By Stock
|
SKN |
Re:
SKN NEW PRODUCT LAUNCH INVISI SHIELD COVID-19
|
|
JSBStrikesBack
|
379 |
92K |
0 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
379
|
92K
|
0
|
|
ASX - By Stock
|
SKN |
Re:
SKN NEW PRODUCT LAUNCH INVISI SHIELD COVID-19
|
|
JSBStrikesBack
|
379 |
92K |
3 |
25/03/20 |
25/03/20 |
ASX - By Stock
|
379
|
92K
|
3
|
|
ASX - By Stock
|
SKN |
Re:
Ann: New Securities Issues
|
|
JSBStrikesBack
|
5 |
1.6K |
2 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
5
|
1.6K
|
2
|
|
ASX - By Stock
|
SKN |
Re:
Ann: New Securities Issues
|
|
JSBStrikesBack
|
5 |
1.6K |
6 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
5
|
1.6K
|
6
|
|
ASX - By Stock
|
SKN |
Re:
Ann: New Securities Issues
|
|
JSBStrikesBack
|
5 |
1.6K |
2 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
5
|
1.6K
|
2
|
|
ASX - By Stock
|
SKN |
Re:
SKN NEW PRODUCT LAUNCH INVISI SHIELD COVID-19
|
|
JSBStrikesBack
|
379 |
92K |
4 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
379
|
92K
|
4
|
|
ASX - By Stock
|
SKN |
Re:
SKN NEW PRODUCT LAUNCH INVISI SHIELD COVID-19
|
|
JSBStrikesBack
|
379 |
92K |
5 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
379
|
92K
|
5
|
|
ASX - By Stock
|
SKN |
Re:
SKN NEW PRODUCT LAUNCH INVISI SHIELD COVID-19
|
|
JSBStrikesBack
|
379 |
92K |
5 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
379
|
92K
|
5
|
|
ASX - By Stock
|
SKN |
Re:
SKN NEW PRODUCT LAUNCH INVISI SHIELD COVID-19
|
|
JSBStrikesBack
|
379 |
92K |
1 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
379
|
92K
|
1
|
|
ASX - By Stock
|
SKN |
Re:
Ann: SKN announcement on Invisi Shield hand sanitiser
|
|
JSBStrikesBack
|
46 |
9.6K |
1 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
46
|
9.6K
|
1
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Suspension from Official Quotation
|
|
JSBStrikesBack
|
59 |
12K |
0 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
59
|
12K
|
0
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Trading Halt
|
|
JSBStrikesBack
|
4 |
2.3K |
2 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
4
|
2.3K
|
2
|
|
ASX - By Stock
|
SKN |
Re:
Is the product availible ?
|
|
JSBStrikesBack
|
2 |
916 |
1 |
07/03/20 |
07/03/20 |
ASX - By Stock
|
2
|
916
|
1
|
|
ASX - By Stock
|
SKN |
Re:
SKN NEW PRODUCT LAUNCH INVISI SHIELD COVID-19
|
|
JSBStrikesBack
|
379 |
92K |
17 |
06/03/20 |
06/03/20 |
ASX - By Stock
|
379
|
92K
|
17
|
|
ASX - By Stock
|
STX |
Re:
Multi generational asset
|
|
JSBStrikesBack
|
152 |
248K |
0 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
152
|
248K
|
0
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Half Yearly Report and Accounts
|
|
JSBStrikesBack
|
1 |
15K |
1 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
1
|
15K
|
1
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Non-Renounceable Issue
|
|
JSBStrikesBack
|
1 |
7.3K |
3 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
1
|
7.3K
|
3
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Non-Renounceable Issue
|
|
JSBStrikesBack
|
7 |
2.3K |
1 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
7
|
2.3K
|
1
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Non-Renounceable Issue
|
|
JSBStrikesBack
|
7 |
2.3K |
0 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
7
|
2.3K
|
0
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Non-Renounceable Issue
|
|
JSBStrikesBack
|
7 |
2.3K |
0 |
11/02/20 |
11/02/20 |
ASX - By Stock
|
7
|
2.3K
|
0
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Non-Renounceable Issue
|
|
JSBStrikesBack
|
7 |
2.3K |
1 |
10/02/20 |
10/02/20 |
ASX - By Stock
|
7
|
2.3K
|
1
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Appendix 4C - quarterly
|
|
JSBStrikesBack
|
1 |
660 |
1 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
1
|
660
|
1
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Non-Renounceable Issue
|
|
JSBStrikesBack
|
4 |
2.1K |
1 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
4
|
2.1K
|
1
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Non-Renounceable Issue
|
|
JSBStrikesBack
|
4 |
2.1K |
1 |
28/01/20 |
28/01/20 |
ASX - By Stock
|
4
|
2.1K
|
1
|
|
ASX - By Stock
|
STX |
Re:
The SP is on the turn
|
|
JSBStrikesBack
|
132 |
103K |
2 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
132
|
103K
|
2
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Response to ASX Query Letter
|
|
JSBStrikesBack
|
43 |
15K |
2 |
29/11/19 |
29/11/19 |
ASX - By Stock
|
43
|
15K
|
2
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Trading Halt
|
|
JSBStrikesBack
|
1 |
978 |
3 |
21/11/19 |
21/11/19 |
ASX - By Stock
|
1
|
978
|
3
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Appendix 4C - quarterly
|
|
JSBStrikesBack
|
5 |
2.6K |
5 |
15/11/19 |
15/11/19 |
ASX - By Stock
|
5
|
2.6K
|
5
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Response to ASX Query
|
|
JSBStrikesBack
|
3 |
1.1K |
5 |
29/10/19 |
29/10/19 |
ASX - By Stock
|
3
|
1.1K
|
5
|
|
ASX - By Stock
|
STX |
Re:
Ann: Outstanding West Erregulla Flow Test Results
|
|
JSBStrikesBack
|
359 |
230K |
4 |
25/10/19 |
25/10/19 |
ASX - By Stock
|
359
|
230K
|
4
|
|
ASX - By Stock
|
STX |
Re:
Ann: 3Q19 Quarterly Activities Report & 5B
|
|
JSBStrikesBack
|
62 |
38K |
33 |
19/10/19 |
19/10/19 |
ASX - By Stock
|
62
|
38K
|
33
|
|